Nanoparticle substances namely, chemical compositions and biochemical preparations in the form of silicon, lipid and hybrid silicon-lipid nanoparticles for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals and vaccines; Nanoparticle substances namely, chemical compositions and biochemical preparations in the form of silicon, lipid and hybrid silicon-lipid nanoparticles for use as stabilizing agents, active pharmaceutical ingredients, drug delivery molecules, carrier substances and buffer compounds, all for use in the development, formulation and manufacture of pharmaceuticals and biopharmaceuticals and vaccines; Silicon namely, silicon nanoparticles for use in industry, science and research; silicon for use in industry, science and research; silicon nanoparticle materials for use in industry, science and research; porous silicon nanoparticle materials for use in industry, science and research; lipid nanoparticles for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-lipid nanoparticles for use in industry, science and research; silicon-stabilised hybrid lipid nanoparticles for use in industry, science and research; silicon-stabilised lipid nanoparticles for use in industry, science and research; stabilised lipid nanoparticles for use in industry, science and research; nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; porous silicon nanoparticles for carrying and delivery of chemical, biochemical and biological substances; lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon¬ stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; porous silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; lipid nanoparticles for stabilising of chemical, biochemical and biological substances; silicon-lipid nanoparticle materials for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; nanoparticles for stabilising nucleic acids; silicon nanoparticle materials for stabilising nucleic acids; porous silicon nanoparticle materials for stabilising nucleic acids; lipid nanoparticles for stabilising nucleic acids; silicon-lipid nanoparticle materials for stabilising nucleic acids; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acids; silicon-stabilised lipid nanoparticles for stabilising nucleic acids; nanoparticles for stabilising nucleic acid-lipid complexes; silicon nanoparticle materials for stabilising nucleic acid-lipid complexes; porous silicon nanoparticle materials for stabilising of nucleic acid-lipid complexes; lipid nanoparticles for stabilising nucleic acid-lipid complexes; silicon-lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexes; silicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes.

Drug delivery agents in the form of nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of silicon nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of porous silicon nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of lipid nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of silicon-lipid hybrid nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of nano-capsules and micro-capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; Silicon nanoparticles for medical, veterinary and pharmaceutical research purposes; porous silicon nanoparticles for medical, veterinary and pharmaceutical research purposes; lipid nanoparticles for medical, veterinary and pharmaceutical research purposes; silicon-lipid hybrid nanoparticles for medical, veterinary and pharmaceutical research purposes; Stabilizing agents for vaccines for humans and for animals; Stabilizing agents for nucleic acids; silicon nanoparticles for stabilizing nucleic acids, silicon nanoparticles for stabilizing nucleic acids; porous silicon nanoparticles for stabilizing nucleic acids, lipid nanoparticles for stabilizing nucleic acids, silicon-lipid hybrid nanoparticles for stabilizing nucleic acids; Stabilizing agents for nucleic acid-lipid complexes; silicon nanoparticles for stabilizing nucleic acid-lipid complexes, silicon nanoparticles for stabilizing nucleic acid-lipid complexes; porous silicon nanoparticles for stabilizing nucleic acid-lipid complexes, lipid nanoparticles for stabilizing nucleic acid-lipid complexes, silicon-lipid hybrid nanoparticles for stabilizing nucleic acid-lipid complexes; Transfection agents for nucleic acids; Silicon nanoparticles for controlled release of nucleic acids; porous silicon nanoparticles for controlled release of nucleic acids; lipid nanoparticles for controlled release of nucleic acids; silicon-lipid hybrid nanoparticles for controlled release of nucleic acids.

Automobiles, trucks, vans, and exterior insignia badges for the foregoing.

Rubber wheels, pneumatic and semi-pneumatic tires and inner tubes for vehicle wheels of every kind.

Pesticides.

Medical and surgical devices, namely, microcatheters for the treatment of vascular anomalies.

Footwear, namely boots, shoes and sandals.

Computer software programs and documentation, namely communication programs allowing users to use their computers to send electronic mail using the Internet or other computer networks.

Radio telephones, cellular telephones, radio transceivers and accessories, namely, microphones, speakers, cases, batteries, battery chargers and handsets.

Rubber wheels, pneumatic and semi-pneumatic tires and inner tubes for vehicle wheels of every kind.

Magazines related to the travel industry.